Business Description
Pharma Resources (Shanghai) Co Ltd
ISIN : CNE1000065Q9
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.15 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 10.58 | |||||
Interest Coverage | 1.42 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 6.67 | |||||
Beneish M-Score | -0.71 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.5 | |||||
3-Year EBITDA Growth Rate | -5.7 | |||||
3-Year EPS without NRI Growth Rate | -24.6 | |||||
3-Year Book Growth Rate | 47.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.59 | |||||
9-Day RSI | 56.89 | |||||
14-Day RSI | 56.92 | |||||
6-1 Month Momentum % | -23.79 | |||||
12-1 Month Momentum % | -42.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.69 | |||||
Quick Ratio | 3.29 | |||||
Cash Ratio | 2.38 | |||||
Days Inventory | 69.16 | |||||
Days Sales Outstanding | 62.74 | |||||
Days Payable | 83.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.4 | |||||
Dividend Payout Ratio | 2.31 | |||||
Forward Dividend Yield % | 1.4 | |||||
5-Year Yield-on-Cost % | 1.4 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -1.3 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.35 | |||||
Operating Margin % | 2.25 | |||||
Net Margin % | 4 | |||||
FCF Margin % | -27.1 | |||||
ROE % | 1.87 | |||||
ROA % | 1.44 | |||||
ROIC % | 2.83 | |||||
ROC (Joel Greenblatt) % | 3.3 | |||||
ROCE % | 1.49 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 176.04 | |||||
Forward PE Ratio | 29.45 | |||||
PE Ratio without NRI | 171.12 | |||||
PEG Ratio | 8.19 | |||||
PS Ratio | 6.78 | |||||
PB Ratio | 3.21 | |||||
Price-to-Tangible-Book | 3.24 | |||||
EV-to-EBIT | 161.8 | |||||
EV-to-EBITDA | 161.8 | |||||
EV-to-Revenue | 5.94 | |||||
EV-to-FCF | -21.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.63 | |||||
Price-to-Graham-Number | 4.96 | |||||
Price-to-Net-Current-Asset-Value | 10.59 | |||||
Price-to-Net-Cash | 40.78 | |||||
Earnings Yield (Greenblatt) % | 0.62 | |||||
FCF Yield % | -4.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharma Resources (Shanghai) Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 517.826 | ||
EPS (TTM) (Â¥) | 0.139 | ||
Beta | 0 | ||
Volatility % | 66.25 | ||
14-Day RSI | 56.92 | ||
14-Day ATR (Â¥) | 1.83592 | ||
20-Day SMA (Â¥) | 22.0245 | ||
12-1 Month Momentum % | -42.52 | ||
52-Week Range (Â¥) | 16.276923 - 42.3 | ||
Shares Outstanding (Mil) | 139.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharma Resources (Shanghai) Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharma Resources (Shanghai) Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Pharma Resources (Shanghai) Co Ltd Frequently Asked Questions
What is Pharma Resources (Shanghai) Co Ltd(SZSE:301230)'s stock price today?
When is next earnings date of Pharma Resources (Shanghai) Co Ltd(SZSE:301230)?
Does Pharma Resources (Shanghai) Co Ltd(SZSE:301230) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |